NextCure, Inc. (NXTC) is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, focused on the discovery and development of innovative immunomedicines aimed at treating cancer and other immune-related diseases. By leveraging its proprietary NEX-T technology platform, NextCure is poised to restore normal immune function and create new therapeutic options for patients with unmet medical needs. As the company advances its pipeline of candidates, it is positioned to make significant contributions to the rapidly evolving field of immunotherapy.
Click "Analyze" to generate stock analysis
NXTC Price Trend and Signals
NXTC Option Volumes & Open Interests (aggregated)
NXTC Put Call Ratios and IV (aggregated)
NXTC Financials
2025-10-29Somewhat Bullishprice_signal
Yearly high detected.
2025-10-29Bullishprice_signal
Large price change detected: 15.65%.
2025-10-22Bearishprice_signal
Large price change detected: -23.41%.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-17Somewhat Bullishprice_signal
Yearly high detected.
2025-10-17Bullishprice_signal
Large price change detected: 37.13%.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.